202 related articles for article (PubMed ID: 27794518)
21. C1 domain residues Lys 2092 and Phe 2093 are of major importance for the endocytic uptake of coagulation factor VIII.
Meems H; van den Biggelaar M; Rondaij M; van der Zwaan C; Mertens K; Meijer AB
Int J Biochem Cell Biol; 2011 Aug; 43(8):1114-21. PubMed ID: 21497669
[TBL] [Abstract][Full Text] [Related]
22. Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism.
Vormittag R; Bencur P; Ay C; Tengler T; Vukovich T; Quehenberger P; Mannhalter C; Pabinger I
J Thromb Haemost; 2007 Mar; 5(3):497-502. PubMed ID: 17155964
[TBL] [Abstract][Full Text] [Related]
23. The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein.
Lenting PJ; Neels JG; van den Berg BM; Clijsters PP; Meijerman DW; Pannekoek H; van Mourik JA; Mertens K; van Zonneveld AJ
J Biol Chem; 1999 Aug; 274(34):23734-9. PubMed ID: 10446132
[TBL] [Abstract][Full Text] [Related]
24. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism.
Saenko EL; Yakhyaev AV; Mikhailenko I; Strickland DK; Sarafanov AG
J Biol Chem; 1999 Dec; 274(53):37685-92. PubMed ID: 10608826
[TBL] [Abstract][Full Text] [Related]
25. Factor VIII C1 domain spikes 2092-2093 and 2158-2159 comprise regions that modulate cofactor function and cellular uptake.
Bloem E; van den Biggelaar M; Wroblewska A; Voorberg J; Faber JH; Kjalke M; Stennicke HR; Mertens K; Meijer AB
J Biol Chem; 2013 Oct; 288(41):29670-9. PubMed ID: 24009077
[TBL] [Abstract][Full Text] [Related]
26. The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues.
Gettins PG; Dolmer K
J Biol Chem; 2016 Jan; 291(2):800-12. PubMed ID: 26555266
[TBL] [Abstract][Full Text] [Related]
27. Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related protein.
Rohlena J; Kolkman JA; Boertjes RC; Mertens K; Lenting PJ
J Biol Chem; 2003 Mar; 278(11):9394-401. PubMed ID: 12522212
[TBL] [Abstract][Full Text] [Related]
28. Expression and characterization of a codon-optimized blood coagulation factor VIII.
Shestopal SA; Hao JJ; Karnaukhova E; Liang Y; Ovanesov MV; Lin M; Kurasawa JH; Lee TK; Mcvey JH; Sarafanov AG
J Thromb Haemost; 2017 Apr; 15(4):709-720. PubMed ID: 28109042
[TBL] [Abstract][Full Text] [Related]
29. High-Affinity Binding of LDL Receptor-Related Protein 1 to Matrix Metalloprotease 1 Requires Protease:Inhibitor Complex Formation.
Arai AL; Migliorini M; Au DT; Hahn-Dantona E; Peeney D; Stetler-Stevenson WG; Muratoglu SC; Strickland DK
Biochemistry; 2020 Aug; 59(32):2922-2933. PubMed ID: 32702237
[TBL] [Abstract][Full Text] [Related]
30. Factor VIII with a 237 amino acid B-domain has an extended half-life in F8-knockout mice.
Bloem E; Karpf DM; Nørby PL; Johansen PB; Loftager M; Rahbek-Nielsen H; Petersen HH; Blouse GE; Thim L; Kjalke M; Bolt G
J Thromb Haemost; 2019 Feb; 17(2):350-360. PubMed ID: 30525289
[TBL] [Abstract][Full Text] [Related]
31. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand.
Gliemann J; Hermey G; Nykjaer A; Petersen CM; Jacobsen C; Andreasen PA
Biochem J; 2004 Jul; 381(Pt 1):203-12. PubMed ID: 15053742
[TBL] [Abstract][Full Text] [Related]
32. LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo.
Bovenschen N; Mertens K; Hu L; Havekes LM; van Vlijmen BJ
Blood; 2005 Aug; 106(3):906-12. PubMed ID: 15840700
[TBL] [Abstract][Full Text] [Related]
33. Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor.
Childers KC; Avery NG; Estrada Alamo KA; Davulcu O; Haynes RM; Lollar P; Doering CB; Coxon CH; Spiegel PC
Blood; 2023 Jul; 142(2):197-201. PubMed ID: 37192299
[TBL] [Abstract][Full Text] [Related]
34. Complement C1q Interacts With LRP1 Clusters II and IV Through a Site Close but Different From the Binding Site of Its C1r and C1s-Associated Proteases.
Fouët G; Gout E; Wicker-Planquart C; Bally I; De Nardis C; Dedieu S; Chouquet A; Gaboriaud C; Thielens NM; Kleman JP; Rossi V
Front Immunol; 2020; 11():583754. PubMed ID: 33193398
[TBL] [Abstract][Full Text] [Related]
35. Recombinant Expression of the Full-length Ectodomain of LDL Receptor-related Protein 1 (LRP1) Unravels pH-dependent Conformational Changes and the Stoichiometry of Binding with Receptor-associated Protein (RAP).
De Nardis C; Lössl P; van den Biggelaar M; Madoori PK; Leloup N; Mertens K; Heck AJ; Gros P
J Biol Chem; 2017 Jan; 292(3):912-924. PubMed ID: 27956551
[TBL] [Abstract][Full Text] [Related]
36. The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
Bovenschen N; Rijken DC; Havekes LM; van Vlijmen BJ; Mertens K
J Thromb Haemost; 2005 Jun; 3(6):1257-65. PubMed ID: 15946216
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for the interaction of low density lipoprotein receptor-related protein 1 (LRP1) with integrin alphaMbeta2: identification of binding sites within alphaMbeta2 for LRP1.
Ranganathan S; Cao C; Catania J; Migliorini M; Zhang L; Strickland DK
J Biol Chem; 2011 Sep; 286(35):30535-30541. PubMed ID: 21676865
[TBL] [Abstract][Full Text] [Related]
38. Generation of a Potent Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Antagonist by Engineering a Stable Form of the Receptor-associated Protein (RAP) D3 Domain.
Prasad JM; Migliorini M; Galisteo R; Strickland DK
J Biol Chem; 2015 Jul; 290(28):17262-8. PubMed ID: 26013822
[TBL] [Abstract][Full Text] [Related]
39. A novel chemical footprinting approach identifies critical lysine residues involved in the binding of receptor-associated protein to cluster II of LDL receptor-related protein.
Bloem E; Ebberink EH; van den Biggelaar M; van der Zwaan C; Mertens K; Meijer AB
Biochem J; 2015 May; 468(1):65-72. PubMed ID: 25728577
[TBL] [Abstract][Full Text] [Related]
40. Amino acid residues 721-729 are required for full factor VIII activity.
Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
